Benitec Biopharma Ltd ADR (BNTC)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from BNTC's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Benitec Biopharma Ltd ADR's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $73,000 | $75,000 | $0 | — | — |
| Net income | -$18M | -$20M | -$22M | -$38M | -$46M |
| Free cash flow | -$16M | -$18M | -$20M | -$24M | -$17M |
| EPS (diluted) | -$2.71 | -$7.06 | -$1.22 | -$1.05 | -$0.98 |
| Operating margin | -24457.5% | -25441.3% | — | — | — |
Where the revenue comes from
Revenue by products, fiscal 2020. Every breakdown, year by year.
Superinvestors who own BNTC
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
New position | $300,796 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Benitec Biopharma Ltd ADR's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Dec 29, 2025 | Suvretta Capital Management, L |
77,387 | $13.44 | $1M |
| Dec 26, 2025 | Suvretta Capital Management, L |
16,836 | $13.10 | $220,552 |
| Dec 23, 2025 | Suvretta Capital Management, L |
50,000 | $12.85 | $642,500 |
| Dec 22, 2025 | Suvretta Capital Management, L |
19,542 | $12.08 | $236,067 |
| Dec 19, 2025 | Suvretta Capital Management, L |
16,384 | $11.48 | $188,088 |
| Dec 18, 2025 | Suvretta Capital Management, L |
10,215 | $11.24 | $114,817 |
| Nov 7, 2025 | Suvretta Capital Management, L |
1,481,481 | $13.50 | $20M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when BNTC trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Benitec Biopharma Ltd ADR insiders buying the stock?
7 open-market insider purchases of BNTC in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Benitec Biopharma Ltd ADR?
1 of the superinvestors Investingly tracks hold BNTC in their latest 13F, including Cliff Asness.
Companies like Benitec Biopharma Ltd ADR
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.